Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
AURA Aura Biosciences
- 8.410
- -0.030-0.36%
Close Dec 13 16:00 ET
- 8.410
- 0.0000.00%
Post 16:00 ET
420.09MMarket Cap-4.86P/E (TTM)
8.510High8.320Low121.52KVolume8.390Open8.440Pre Close1.02MTurnover0.35%Turnover RatioLossP/E (Static)49.95MShares12.37852wk High2.40P/B289.67MFloat Cap6.63052wk Low--Dividend TTM34.44MShs Float26.160Historical High--Div YieldTTM2.25%Amplitude5.990Historical Low8.407Avg Price1Lot Size
Aura Biosciences News
Aura Biosciences | 10-Q: Q3 2024 Earnings Report
Aura Biosciences | 8-K: Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
Aura Biosciences | 10-Q: Q2 2024 Earnings Report
Aura Biosciences | 8-K: Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights
Aura Biosciences | 10-K/A: Annual report (Amendment)
Aura Biosciences | 10-Q: Q1 2024 Earnings Report
Aura Biosciences | 8-K: Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
Aura Biosciences | 10-K: FY2023 Annual Report
Aura Biosciences | 8-K: Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Aura Biosciences | 10-Q: Q3 2023 Earnings Report
Aura Biosciences | 10-Q: Q2 2023 Earnings Report
Aura Biosciences | 8-K: Aura Biosciences Reports Second Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
Aura Biosciences | 10-Q: Q1 2023 Earnings Report
Aura Biosciences | 8-K: Aura Biosciences Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
Aura Biosciences | 10-K: FY2022 Annual Report
Aura Biosciences | 8-K: Aura Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights
Aura Biosciences | 10-Q: Q3 2022 Earnings Report
Aura Biosciences | 8-K: Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
Aura Biosciences | 10-Q: Q2 2022 Earnings Report
Aura Biosciences | 8-K: Aura Biosciences Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.